Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons dr. O.W. Akkerman

Speerpunten

Farmacokinetiek en farmacodynamiek van tuberculose medicijnen

Inhalatie van antimicrobiele medicatie

De holistische benadering van de behandeling van tuberculose

Publicaties

Availability and costs of medicines for the treatment of tuberculosis in Europe

Bedaquiline exposure in people with drug-resistant TB treated for diabetes: analysis of two phase 2 trials

Characteristics and mortality of central nervous system TB in the Netherlands: a 15-year comparison with other forms of TB

Clinical presentation of pulmonary and extrapulmonary tuberculosis

Clinical standards for the management of adverse effects during treatment for TB

Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment

Diagnosis, treatment and transmission of rifampicin-resistant TB in the Netherlands, 2010-2019

Epidemiology and management of nontuberculous mycobacterial disease in people with cystic fibrosis, the Netherlands

Eradication of Burkholderia cepacia complex in cystic fibrosis patients with inhalation of amiloride and tobramycin combined with oral cotrimoxazole

Identification of circulating monocytes as producers of tuberculosis disease biomarker C1q

Lees meer

Pers/media

‘Belet met therapeutic drug monitoring resistentie tegen tbc-behandeling’

Therapietrouw tbc-patiënten verbeteren met slim pillenpotje

RTL EditieNL: Corona

Focus (NTR): Massale reisgedrag en tuberculose

Lees meer